Abnormal maternal serum chorionic gonadotropin levels in pregnancies with fetal chromosome abnormalities

No abstract is available for this paper.

• Publication year

  1987

• Venue

  Prenatal Diagnosis

• Publication date

  1987-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/pd.1970070904PMID 2447576
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Maternal serum alpha-fetoprotein and fetal autosomal trisomies.

  1986cited by this paper
• Maternal serum α-fetoprotein and fetal autosomal trisomies

  1986cited by this paper
• Changes in the incidence of Down syndrome in Sweden during 1968-1982.

  1986cited by this paper
• An association between low maternal serum alpha-fetoprotein and fetal chromosomal abnormalities.

  1984cited by this paper
• Maternal age specific rates for chromosome aberrations and factors influencing them: Report of a collaborative european study on 52 965 amniocenteses

  1984cited by this paper
• An association between low maternal serum α-fetoprotein and fetal chromosomal abnormalities

  1984cited by this paper
• The production of monoclonal antibodies to human chorionic gonadotrophin and its subunits.

  1983cited by this paper
• Early embryonic mortality in women.

  1983cited by this paper
• Immunological Properties of the β-Subunit of HumanChorionic Gonadotropin (hCG). II. Properties of a hCGSpecific Antibody Prepared against a Chemical Analog of the β-Subunit

  1980cited by this paper
• Immunological properties of the beta-subunit of human chorionic gonadotropin (hCG). II. Properties of a hCG-specific antibody prepared against a chemical analog of the beta subunit.

  1980cited by this paper
• The importance of accurate gestational age estimation in screening for fetal neural tube defects using maternal serum alpha-fetoprotein levels.

  1978cited by this paper
• Serum human chorionic gonadotropin levels throughout normal pregnancy.

  1976cited by this paper
• The Epidemiology of Human Spontaneous Abortions with Chromosomal Anomalies

  1975cited by this paper
• Lactogenic Hormones, Fetal Nutrition, and Lactation

  1975cited by this paper
• [Radioimmunoassay of alpha-fetoprotein in primary and secondary cancer of the liver].

  1972cited by this paper
• Human Chorionic Gonadotropin in Abnormal Pregnancy. Serum and Urinary Findings Using Various Immunoassay Techniques

  1965cited by this paper

• Hormone chorionique gonadotrope humaine et ses sous-unités libres

  2024cites this paper
• The effect of a vanishing twin on first- and second-trimester maternal serum markers and ultrasound screening for aneuploidy

  2023cites this paper
• Down Syndrome Screening among Pregnant Women Visiting the Department of Obstetrics and Gynaecology of a Tertiary Care Centre

  2023cites this paper
• Prenatal Screening of Cytogenetic Anomalies -A Ten Year Retrospective Study on 1510 Cases

  2023cites this paper
• Biochemical Screening for Fetal Trisomy 21: Pathophysiology of Maternal Serum Markers and Involvement of the Placenta

  2023cites this paper
• Current controversies in prenatal diagnosis: Noninvasive prenatal testing should replace other screening strategies for fetal trisomies 13, 18, 21

  2023cites this paper
• The relationship between TSH levels, maternal characteristics and racial group of the aneuploidy screening

  2022cites this paper
• Human Chorionic Gonadotropin—A Review of the Literature

  2022cites this paper
• Developing computational methods and workflows for targeted and whole-genome sequencing based non-invasive prenatal testing

  2022cites this paper
• Prenatal Screening for Neural Tube Defects and Aneuploidy

  2022cites this paper
• An enzyme immunoassay to determine human chorionic gonadotropin (HCG) in serum and urine samples using an ultra-microanalytical system.

  2021cites this paper
• Innovations in Placental Pathology

  2021cites this paper
• Clinical manifestations of placental mesenchymal dysplasia in Japan: A multicenter case series

  2021cites this paper
• Abortion and Chromosomal Anomalies

  2021cites this paper
• Second-trimester screening for fetal abnormalities

  2021cites this paper
• Stratégie de dépistage de la trisomie 21

  2021cites this paper
• Prenatal Tarama Testleri ve Hücreden Bağımsız Fetal DNA

  2020cites this paper
• Non-Invasive Prenatal Testing: Current Perspectives and Future Challenges

  2020cites this paper
• Imaging findings in association with altered maternal alpha-fetoprotein levels during pregnancy

  2020cites this paper
• Unbalanced human embryos secrete more hyperglycosylated human chorionic gonadotrophin (hCG-H) than balanced ones

  2020cites this paper
• Trisomy 21 is Associated with Caspase-2 Upregulation in Cytotrophoblasts at the Maternal-Fetal Interface

  2020cites this paper
• Serum and Ultrasound Based Screening Tests for Aneuploidy

  2019cites this paper
• Recurrence of extreme serum analytes in consecutive pregnancies and association with obstetrical outcomes*

  2019cites this paper
• Prenatal Diagnosis

  2019cites this paper
• A preeclampsia risk prediction model based on maternal characteristics and serum markers in twin pregnancy

  2019cites this paper
• Sequencing Cell-Free DNA in the Maternal Circulation to Screen for Down Syndrome, Other Common Trisomies, and Selected Genetic Disorders

  2018cites this paper
• Quad Screen Test, A Multiplexed Biomarker Assay for Prenatal Screening to Assess Birth Defects: The Columbia University Experience Using the Beckman Access2 Immunoassay Analyzer and Benetech PRA.

  2018cites this paper
• Prenatal diagnosis

  2018cites this paper
• Chapter 5 Prenatal Diagnosis of Down Syndrome

  2018cites this paper
• Effect of Male Partner’s Involvement in a Woman’s Prenatal Decision-Making Process

  2018cites this paper
• Prenatal Biochemical and Ultrasound Markers in Chromosomal Anomalies

  2018cites this paper
• Traditional Prenatal Diagnosis: Past to Present.

  2018cites this paper
• Prenatal Diagnosis of Down Syndrome

  2018cites this paper
• Noninvasive Approaches to Prenatal Diagnosis: Historical Perspective and Future Directions.

  2018cites this paper
• Performance and Predictive Value of First Trimester Screening Markers for Down Syndrome in Iranian Pregnancies

  2018cites this paper
• A prospective clinical trial to compare the performance of dried blood spots prenatal screening for Down’s syndrome with conventional non-invasive testing technology

  2017cites this paper
• The magnitude of elevated maternal serum human chorionic gonadotropin and pregnancy complications

  2017cites this paper
• First trimester ultrasound tests alone or in combination with first trimester serum tests for Down's syndrome screening.

  2017cites this paper
• Patent Number : ( 45 ) Date of Patent : 5 , 716 , 776 Feb

  2017cites this paper
• The maternal plasma proteome changes as a function of gestational age in normal pregnancy: a longitudinal study

  2017cites this paper
• Análisis de resultados «falsos negativos» para trisomía 21 en los programas de cribado combinado de primer trimestre: una herramienta para la mejora de la calidad

  2017cites this paper
• First and second trimester serum tests with and without first trimester ultrasound tests for Down's syndrome screening.

  2017cites this paper
• Expanded conventional first trimester screening

  2017cites this paper
• Screening for fetal aneuploidy.

  2016cites this paper
• THE COMPARISON OF SECOND TRIMESTER SCREENING TESTS WITH THE WHITE BLOOD CELL COUNTS

  2016influential citation
• Advanced maternal age : identifying mechanisms underlying vulnerability to stillbirth

  2016cites this paper
• Современные принципы пренатального скрининга

  2016cites this paper
• Efectividad del doble test bioquõ´mico como prueba de cribado de sõ´ndrome de Down en el segundo trimestre

  2016cites this paper
• First trimester combined screening – focus on early biochemistry

  2016cites this paper
• Cell-free fetal DNA (cffDNA) enrichment for non-invasive prenatal testing (NIPT) : a comparison of molecular techniques

  2016cites this paper
• hCG - related molecules and their measurement.

  2016cites this paper
• Aneuploidy Screening in Pregnancy.

  2016cites this paper
• Direct Reading of Bona Fide Barcode Assays for Diagnostics with Smartphone Apps

  2015cites this paper
• Le dépistage prénatal de la trisomie 21 : étude des connaissances et de la participation des pères

  2015cites this paper
• First trimester serum tests for Down's syndrome screening.

  2015cites this paper
• Detecting Down syndrome pregnancies and preeclampsia

  2015cites this paper
• Urine tests for Down's syndrome screening.

  2015cites this paper
• Maternal Serum Screening for Chromosomal Abnormalities and Neural Tube Defects

  2015cites this paper
• Clinical Applications of Noninvasive Prenatal Testing

  2015cites this paper
• Abnormal Biochemical Analytes Used for Aneuploidy Screening and Adverse Pregnancy Outcomes in Twin Gestations

  2015cites this paper
• Prenatal maternal serum screening for fetal aneuploidy

  2015cites this paper
• Sequencing Cell Free DNA in the Maternal Circulation to Screen for Down Syndrome and Other Common Aneuploidies

  2015cites this paper
• The effect of inherited thrombophilia on second trimester combined aneuploidy screening test markers

  2015cites this paper
• Prenatal screening strategies, long-term outcome of children with marked changes in maternal screening tests and the most common syndromic heart anomalies in Estonia

  2014cites this paper
• Influencia de las técnicas de reproducción asistida en el cribado de aneuploidías de las 11-13 semanas

  2014cites this paper
• A historical and practical review of first trimester aneuploidy screening.

  2014cites this paper
• hCG in screening for aneuploidy: a possible role for its glycoforms?

  2014cites this paper
• [Interpretation of atypical values of maternal serum markers].

  2014cites this paper
• The Triple Test Markers Profile Among Fetuses and Children Diagnosed With Umbilical Vein Varix

  2014influential citation
• Screening for abnormal placentation and adverse pregnancy outcomes with maternal serum biomarkers in the second trimester

  2014cites this paper
• Noninvasive Prenatal Detection of Aneuploidy

  2014cites this paper
• Diagnóstico pré-natal: retrospectiva

  2014cites this paper
• Analysis of Second Trimester Maternal Quadruple Screening Test for Trisomy 21 and Trisomy 18

  2014cites this paper
• Screening for Down syndrome

  2014cites this paper
• Serological prenatal screening and diagnosis for Down syndrome.

  2014cites this paper
• Pregnancy associated plasma protein-A2: a novel biomarker for Down syndrome.

  2014cites this paper
• Impact of Cell-Free Fetal DNA Screening on Patients’ Choice of Invasive Procedures after a Positive California Prenatal Screen Result

  2014cites this paper
• Non-Invasive Screening Tools for Down’s Syndrome: A Review

  2013cites this paper
• Interprétation des valeurs atypiques des marqueurs sériques Interpretation of atypical values of maternal serum markers

  2013cites this paper
• [First trimester screening for Down syndrome in a French perinatal healthcare network].

  2013cites this paper
• First‐trimester Down syndrome screening in renal‐transplanted pregnant women: a model for adjusting the false‐positives rates

  2013cites this paper
• Down Syndrome: Clinical and Genetic Aspects, Genetic Counseling and Prenatal Screening and Diagnosis

  2013cites this paper
• Screening for down syndrome in the United States: results of surveys in 2011 and 2012.

  2013influential citation
• Impact of diabetes on aneuploidy screening.

  2013cites this paper
• First and second trimester hCG levels have no value in predicting small for gestational age

  2013cites this paper
• Maternal Serum Human Chorionic Gonadotropin and Magnesium as Biochemical Markers in Predicting Preeclampsia in Pregrant Ghanaian Women

  2013cites this paper
• Information et compréhension du test de dépistage de la trisomie 21 par les patientes

  2013cites this paper
• Prenatal Screening for Neural Tube Defects and Aneuploidy

  2013cites this paper
• Analysis of the impact of PAPP-A, free β-hCG and nuchal translucency thickness on the advanced first trimester screening

  2013cites this paper
• Prenatal screening for fetal aneuploidies during the first and second trimester of pregnancy

  2013cites this paper
• Abortion, Placentas of Trisomies, and Immunological Considerations of Recurrent Reproductive Failure

  2012cites this paper
• Trizomi 18 ve 13 Olgularinda Ultrasonografi Bulgulari Sonographic Features in Cases with Trisomy 18 and 13

  2012cites this paper
• Feasibility of Using Plasma Rather Than Serum in First and Second Trimester Multiple Marker Down's Syndrome Screening

  2012cites this paper
• Contributo para a melhoria da acuidade do diagnóstico pré-natal: análise crítica da correlação entre o diagnóstico pré-natal e o diagnóstico post-mortem

  2012cites this paper
• First Trimester Maternal Serum Screening Using Biochemical Markers PAPP-A and Free β-hCG for Down Syndrome, Patau Syndrome and Edward Syndrome

  2012cites this paper
• hCG, five independent molecules.

  2012cites this paper
• Ranta-Ylikulju First Trimester Down ́ s Syndrome Screening

  2012cites this paper
• Second trimester serum tests for Down's Syndrome screening.

  2012cites this paper
• Pregnancy and delivery outcomes following a pathological second trimester triple test screening result and a normal karyotype

  2012cites this paper
• Pregnancy and Its Disorders

  2012cites this paper